Patents by Inventor Michel Andre

Michel Andre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7161171
    Abstract: A material including a glass or vitroceramic substrate having a first layer and a second layer deposited thereon, each of the first and second layers including at least one transparent conducting oxide (TCO). The first layer has a roughness of more than 1 nm and the second layer has a roughness less than or equal to 1 nm. A transmittance in the visible wavelength range of the material is at least 80%. The work function of the second layer is greater than the work function of the first layer and is greater than 4.6 eV.
    Type: Grant
    Filed: September 2, 2003
    Date of Patent: January 9, 2007
    Assignee: Corning Incorporated
    Inventors: Brahim Dahmani, Guillaume Guzman, Michel André Aegerter, Jörg Pütz
  • Patent number: 7105533
    Abstract: Phenyl compounds substituted with a fused-heterobicyclo moiety, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, and panic, as well as in the treatment of pain and other diseases.
    Type: Grant
    Filed: September 9, 2003
    Date of Patent: September 12, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Brian Thomas Campbell, Janet Lorraine Gunzer, Benito Munoz, Brian Andrew Stearns, Jean-Michel Andre Vernier, Bowei Wang
  • Patent number: 7081248
    Abstract: A water-dispersible vitamin composition containing Vitamins A, D3 or E, or a precursor thereof, an alkyl lactate and an emulsifier and is substantially free of water.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: July 25, 2006
    Assignee: Adisseo France S.A.S.
    Inventor: Michel Andre Crepeau
  • Patent number: 7060080
    Abstract: A surgical ring (1) designed to be implanted around (a) biological organ(s), the ring (1) being formed by a flexible band (2) including a first and second extremity (3, 4), the flexible band (2) being designed to be closed near its two extremities (3, 4) by a closure system so as to form a closed loop featuring an internal contact surface (2A) external 10 surface (2B). The closure system includes a means of encircling (5) that is integral with the first extremity (3) and arranged to evolve between a de-latching configuration, where the means of encircling (5) forms an open collar freeing the second extremity (4), and a latching configuration where the means of encircling (5) forms a closed collar designed to surround the second extremity (4) so as to unite it with the first extremity (3), the closed collar having opposite front (6) and rear (7) faces, between which an encircling opening extends that is designed to accept the second extremity (4).
    Type: Grant
    Filed: September 3, 2003
    Date of Patent: June 13, 2006
    Assignee: Endoart S.A.
    Inventor: Michel Andre Bachmann
  • Publication number: 20050122988
    Abstract: Network-units (4) comprising multicast driver devices (3) handle multicast messages efficiently by providing the multicast driver devices (3) with memory nodes (1,2) arranged in rows and/or columns, with a memory node (1,2) comprising a memory element (31-33) for memorising a state of the memory node (1,2). Large numbers of multicast cells/groups like multicast cells and/or multicast groups can be served advantageously. M×N memory nodes (1,2) are arranged in M rows and N columns, with a memory node (1,2) comprising an engagement line (11), an unavailability line (12) and an identification line (13) per row and a request line (21), an acknowledgement line (22) and a selection line (23) per column. A memory element (31,32) memorises a state indicating a destination port being used for a multicast cell/group, and a further memory element (33) indicates a state requesting a generation of a multicast copy for a destination port, all according to a rule of exclusiveness.
    Type: Application
    Filed: November 30, 2004
    Publication date: June 9, 2005
    Inventor: Michel Andre Henrion
  • Patent number: 6852332
    Abstract: A liquid vitamin composition comprising (a) a first liquid vitamin formulation comprising vitamins A, D3, B12 and optionally vitamin E, (b) a second liquid vitamin formulation comprising vitamins B1, B2, B3, B5, B6, and H, and (c) a third liquid vitamin formulation comprising vitamin K3 wherein the three formulations are separate solutions.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: February 8, 2005
    Assignee: Adisseo France S.A.S.
    Inventors: Michel André Crepeau, Patrick De Lanty, Jean-Marie Dollat, David Muysson
  • Publication number: 20050016602
    Abstract: The present invention relates to a valve device for regulating a fluid, particularly a gaseous fluid, in a conduit portion, comprising a valve body fixed to a support spindle extending transversely into said portion and mounted with the ability to rotate therein, said conduit portion comprising, on either side of said spindle, opposing internal steps forming two bearing surface portions for corresponding edge parts of said valve body, in the closure position thereof, each step extending substantially over approximately half of the internal circumference of the conduit portion in the region of the mounting position of the support spindle.
    Type: Application
    Filed: June 10, 2004
    Publication date: January 27, 2005
    Inventors: Arnaud Schub, Michel Andres
  • Publication number: 20040209800
    Abstract: The invention provides a method of reducing cancer progression comprising administering a Mx polypeptide or Mx-encoding nucleic acid to a host, such that the growth rate of the cancer cells is reduced, the metastatic potential of the cancer cells is reduced, or both. The invention also provides a method of assessing the metastatic potential of a cancer comprising (a) obtaining a sample of the cancer, (b) determining the level of Mx, Mx-nucleic acid, or both in the sample, and (c) comparing the level of Mx, Mx-encoding nucleic acid, or both with a control.
    Type: Application
    Filed: April 9, 2004
    Publication date: October 21, 2004
    Inventors: J. Frederic Mushinski, Jane B. Trepel, Michel Andre Horisberger, Phuongmai Nguyen, Chand Khanna
  • Publication number: 20040175462
    Abstract: The invention relates to a frozen dessert, which, independently of any incorporation of gas, is malleable and extrudable at the freezing temperatures. This dessert includes water, proteins, fat, sweetening agents and at least one stabilizing agent, with the sweetening agents forming a mixture which contains glucose and optionally fructose. These two compounds constitute, as a whole, from 6 to 30% of the total weight of the composition. The frozen dessert includes a nucleating agent, in particular microcrystalline cellulose. The invention relates, in addition, to a process for producing such a dessert, such a packaged dessert and a container for its packaging and its distribution.
    Type: Application
    Filed: March 18, 2004
    Publication date: September 9, 2004
    Inventors: Philippe Jerome Didier Riviere, Stephane Silvente, Frank Manuel Tonon, Veronique Suzanne Michele Andre-Linet
  • Patent number: 6774138
    Abstract: In accordance with the present invention, there is provided a novel class of heterocyclic compounds. Compounds of the invention contain a substituted, unsaturated five, six or seven membered heterocyclic ring that includes at least one nitrogen atom and at least one carbon atom. The ring additionally includes three, four or five atoms independently selected from carbon, nitrogen, sulfur and oxygen atoms. The heterocyclic ring has at least one substituent located at a ring position adjacent to a ring nitrogen atom. This mandatory substituent of the ring includes a moiety (B), linked to the heterocyclic ring via a carbon-carbon double bond, a carbon-carbon triple bond or an azo group. The mandatory substituent is positioned adjacent to the ring nitrogen atom. Invention compounds are capable of a wide variety of uses. For example heterocyclic compounds can act to modulate physiological processes by functioning as agonists and antagonists of receptors in the nervous system.
    Type: Grant
    Filed: August 13, 2002
    Date of Patent: August 10, 2004
    Assignee: Merck & Co., Inc.
    Inventors: Nicholas David Peter Cosford, Leo Solomon Bleicher, Jean-Michel Andre Vernier, Rowena V. Cube, Edwin Schweiger, Ian McDonald
  • Patent number: 6758208
    Abstract: A compact, highly flexible and efficient, multi-positionable, multi-dimensional and multi-stage gas-fired heat exchanger system as described. The system is connectable in a forced air duct regardless of the angular position and size of the duct. The heat exchanger comprises one or more heat transfer tubes which are shaped and dimensioned as dictated by the customized use of the heat exchanger. The tubes are secured to a support panel as well as the gas burner associated with each of the inlet openings of the tubes. A position orientable gas valve is secured to a gas distribution manifold. A turbulator may be associated with at least some of the tubes to cause turbulence in the hot combustion flow in each of the tubes to modify the efficiency in heat transfer along one or more sections of the tubes by directing hot combustion gas along an inner circumferential wall of the tubes.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: July 6, 2004
    Assignees: Technologies Echangeur Gaz Air (TEGA) Inc., Gaz Métropolitain, Centre des Technologies du Gaz Naturel
    Inventors: Laurent Giérula, Michel André Lamarche
  • Publication number: 20040115315
    Abstract: The present invention relates to encapsulated lactic acid, where lactic acid is in a solid, pure, crystalline form. The encapsulation of food acids is common practice. Many companies produce encapsulated citric, tartaric and sorbic acids or GDL. However, lactic acid, a major food acid for its flavour and conservation effect, is not available in a pure solid crystalline encapsulated form. As no substrate is needed for said coated solid lactic acid particles, the lactic acid content of said particles may be very high and the activity of the lactic acid is not impaired by the substrate. Furthermore, the encapsulated solid lactic acid particles according to the invention are easy to handle and are less expensive than encapsulated liquid lactic acid.
    Type: Application
    Filed: August 1, 2003
    Publication date: June 17, 2004
    Inventors: Damien Michel Andre Camelot, Elize Willem Bontenbal
  • Patent number: 6747173
    Abstract: The invention relates to a method for the preparation of lactic acid and calcium sulphate, in which (a) an aqueous solution that contains lactate is reacted with sulphuric acid at a temperature that is essentially higher than the transition temperature of calcium sulphate dihydrate (CaSO4.2H2O), with the formation of a mixture that contains calcium sulphate hemihydrate and lactic acid, (b) the mixture from step (a) is subjected to at least one recrystallisation step at a temperature that is essentially lower than the transition temperature of calcium sulphate dihydrate, with the formation of a precipitate of calcium sulphate dihydrate and an aqueous solution of lactic acid, and (c) the precipitate of calcium sulphate dihydrate is separated off from the aqueous solution of lactic acid.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: June 8, 2004
    Assignee: Purac Biochem B.V.
    Inventors: Markus Gerkema, Aldwin Korevaar, Damien Michel Andre Camelot, Jan Van Breugel, Geert-Jan Witkamp, Agusti CerdàBaro
  • Publication number: 20040018217
    Abstract: A liquid vitamin composition comprising (a) a first liquid vitamin formulation comprising vitamins A, D3, B12 and optionally vitamin E, (b) a second liquid vitamin formulation comprising vitamins B1, B2, B3, B5, B6, and H, and (c) a third liquid vitamin formulation comprising vitamin K3 wherein the three formulations are separate solutions.
    Type: Application
    Filed: January 3, 2003
    Publication date: January 29, 2004
    Inventors: Michel Andre Crepeau, Patrick De Lanty, Jean-Marie Dollat, David Muysson
  • Patent number: 6651463
    Abstract: This knitted boxer comprises a shorts part (3) forming two leg openings and a crotch part; the crotch part is made of a knitted part of two adjacent pieces of different tension, with a pinched piece (25) sewn onto a front seam (10) connecting the two leg openings and a non-pinched part sewn onto a rear seam connecting the two leg openings, the rear seam being longer than the front seam.
    Type: Grant
    Filed: December 12, 2002
    Date of Patent: November 25, 2003
    Assignee: Sara Lee Corporation
    Inventor: Michel Andre Bonnin
  • Publication number: 20030210695
    Abstract: A method is described for forwarding a data packet within a subnetwork (S) of interconnected cell switching nodes (1,2,3,4), surrounded by edge packet routers (A,B,C,D,E), which are further surrounded and part of a data packet network of routers. Said data packet enters said subnetwork via an ingress edge packet router (B), passes through at least one cell switching node (1), and leaves it via at least one destination egress edge packet router (A,C,D,E). The method includes the steps of associating a destination forwarding tag to said data packet, of deriving a sequence of fixed length cells for further transmission to said at least one cell switching node (1), of dynamically analyzing said destination forwarding tag for elaborating a packet cell forwarding decision applicable to all cells of said sequence, and thereby performing a subsequent transfer action of said all cells, to at least one outgoing link.
    Type: Application
    Filed: April 25, 2003
    Publication date: November 13, 2003
    Applicant: ALCATEL
    Inventor: Michel Andre Robert Henrion
  • Patent number: 6632966
    Abstract: The invention relates to a method for the preparation of lactic acid and calcium sulphate, in which (a) an aqueous solution that contains lactate is reacted with sulphuric acid at a temperature that is essentially higher than the transition temperature of calcium sulphate dihydrate (CaSO4.2H2O), with the formation of a mixture that contains calcium sulphate hemihydrate and lactic acid, (b) the mixture from step (a) is subjected to at least one recrystallization step at a temperature that is essentially lower than the transition temperature of calcium sulphate dihydrate, with the formation of a precipitate of calcium sulphate dihydrate and an aqueous solution of lactic acid, and (c) the precipitate of calcium sulphate dihydrate is separated off from the aqueous solution of lactic acid.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: October 14, 2003
    Assignee: Purac Biochem B.V.
    Inventors: Markus Gerkema, Aldwin Korevaar, Damien Michel Andre Camelot, Jan Van Breugel, Geert-Jan Witkamp, Agusti Cerdà Baro
  • Publication number: 20030140661
    Abstract: This knitted boxer comprises a shorts part (3) forming two leg openings and a crotch part; the crotch part is made of a knitted part of two adjacent pieces of different tension, with a pinched piece (25) sewn onto a front seam (10) connecting the two leg openings and a non-pinched part sewn onto a rear seam connecting the two leg openings, the rear seam being longer than the front seam.
    Type: Application
    Filed: December 12, 2002
    Publication date: July 31, 2003
    Inventor: Michel Andre Bonnin
  • Publication number: 20030125581
    Abstract: The invention relates to a method for the preparation of lactic acid and calcium sulphate, in which (a) an aqueous solution that contains lactate is reacted with sulphuric acid at a temperature that is essentially higher than the transition temperature of calcium sulphate dihydrate (CaSO4.2H2O), with the formation of a mixture that contains calcium sulphate hemihydrate and lactic acid, (b) the mixture from step (a) is subjected to at least one recrystallisation step at a temperature that is essentially lower than the transition temperature of calcium sulphate dihydrate, with the formation of a precipitate of calcium sulphate dihydrate and an aqueous solution of lactic acid, and (c) the precipitate of calcium sulphate dihydrate is separated off from the aqueous solution of lactic acid.
    Type: Application
    Filed: August 29, 2002
    Publication date: July 3, 2003
    Inventors: Markus Gerkema, Aldwin Korevaar, Damien Michel Andre Camelot, Jan Van Breugel, Geert-Jan Witkamp, Agusti Cerda Baro
  • Patent number: 6568043
    Abstract: The collar is formed by rolling up a strip (10). First fastening means formed by a hook (14) projecting radially are located at a first end (10A) of the strip, while second fastening means comprising a retaining element (12) projecting radially and suitable for constituting with said hook to close the collar are located at the second end (10B) of the strip. The free edge (14A) of the hook is suitable for being engaged beneath a rim (13) formed to project radially outside relative to the collar in the vicinity of the retaining means (12) while the retaining means are engaged beneath the hook so as to close the collar. The hook is preferably formed by an embossed projection regardless of whether or not the rim (13) is present.
    Type: Grant
    Filed: February 12, 2002
    Date of Patent: May 27, 2003
    Assignee: Etablissements Caillau
    Inventors: Pascal Detable, Henri Viratelle, Michel Andre